As it can interact with other medicines, Zokinvy (lonafarnib) shouldn't be taken along with a powerful or moderate CYP3A inhibitor or inducer, in addition to midazolam and specified cholesterol-decreasing drugs.onePresented the restricted regulatory infrastructure and reliance on WHO prequalification or approvals from stringent authorities, the pos